Oppenheimer & Co’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,450
| Closed | -$13.2K | – | 1496 |
|
|
2023
Q1 | $13.2K | Sell |
1,450
-587
| -29% | -$5.34K | ﹤0.01% | 1372 |
|
|
2022
Q4 | $23.9K | Sell |
2,037
-1,173
| -37% | -$13.8K | ﹤0.01% | 1330 |
|
|
2022
Q3 | $68K | Sell |
3,210
-50
| -2% | -$1.06K | ﹤0.01% | 1317 |
|
|
2022
Q2 | $80K | Sell |
3,260
-87
| -3% | -$2.14K | ﹤0.01% | 1349 |
|
|
2022
Q1 | $166K | Buy |
3,347
+930
| +38% | +$46.1K | ﹤0.01% | 1381 |
|
|
2021
Q4 | $170K | Buy |
2,417
+53
| +2% | +$3.73K | ﹤0.01% | 1411 |
|
|
2021
Q3 | $220K | Sell |
2,364
-134
| -5% | -$12.5K | ﹤0.01% | 1360 |
|
|
2021
Q2 | $251K | Sell |
2,498
-348
| -12% | -$35K | ﹤0.01% | 1334 |
|
|
2021
Q1 | $265K | Buy |
2,846
+212
| +8% | +$19.7K | 0.01% | 1237 |
|
|
2020
Q4 | $217K | Buy |
2,634
+34
| +1% | +$2.8K | ﹤0.01% | 1216 |
|
|
2020
Q3 | $223K | Buy |
2,600
+1,307
| +101% | +$112K | 0.01% | 1116 |
|
|
2020
Q2 | $120K | Buy |
1,293
+420
| +48% | +$39K | ﹤0.01% | 1195 |
|
|
2020
Q1 | $25K | Buy |
873
+343
| +65% | +$9.82K | ﹤0.01% | 1173 |
|
|
2019
Q4 | $22K | Buy |
+530
| New | +$22K | ﹤0.01% | 1266 |
|